UNITY Biotechnology (UBX) Competitors $0.18 -0.12 (-40.43%) Closing price 07/8/2025Extended Trading$0.18 0.00 (0.00%) As of 07/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock UBX vs. IMCC, ALVR, IBIO, PHIO, BTAI, AIMD, CYCN, NKGN, PHXM, and LIXTShould you be buying UNITY Biotechnology stock or one of its competitors? The main competitors of UNITY Biotechnology include IM Cannabis (IMCC), AlloVir (ALVR), iBio (IBIO), Phio Pharmaceuticals (PHIO), BioXcel Therapeutics (BTAI), Ainos (AIMD), Cyclerion Therapeutics (CYCN), NKGen Biotech (NKGN), PHAXIAM Therapeutics (PHXM), and Lixte Biotechnology (LIXT). These companies are all part of the "pharmaceutical products" industry. UNITY Biotechnology vs. Its Competitors IM Cannabis AlloVir iBio Phio Pharmaceuticals BioXcel Therapeutics Ainos Cyclerion Therapeutics NKGen Biotech PHAXIAM Therapeutics Lixte Biotechnology UNITY Biotechnology (NASDAQ:UBX) and IM Cannabis (NASDAQ:IMCC) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends. Which has stronger earnings & valuation, UBX or IMCC? IM Cannabis has higher revenue and earnings than UNITY Biotechnology. IM Cannabis is trading at a lower price-to-earnings ratio than UNITY Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUNITY BiotechnologyN/AN/A-$25.99M-$1.62-0.11IM Cannabis$39.44M0.29-$7.72M-$0.64-4.39 Is UBX or IMCC more profitable? UNITY Biotechnology has a net margin of 0.00% compared to IM Cannabis' net margin of -9.10%. IM Cannabis' return on equity of -122.96% beat UNITY Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets UNITY BiotechnologyN/A -246.82% -58.81% IM Cannabis -9.10%-122.96%-11.69% Do insiders and institutionals believe in UBX or IMCC? 29.5% of UNITY Biotechnology shares are held by institutional investors. Comparatively, 7.7% of IM Cannabis shares are held by institutional investors. 5.8% of UNITY Biotechnology shares are held by insiders. Comparatively, 5.9% of IM Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more risk and volatility, UBX or IMCC? UNITY Biotechnology has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500. Comparatively, IM Cannabis has a beta of 2.19, meaning that its share price is 119% more volatile than the S&P 500. Does the media refer more to UBX or IMCC? In the previous week, IM Cannabis had 1 more articles in the media than UNITY Biotechnology. MarketBeat recorded 1 mentions for IM Cannabis and 0 mentions for UNITY Biotechnology. IM Cannabis' average media sentiment score of 1.89 beat UNITY Biotechnology's score of 0.00 indicating that IM Cannabis is being referred to more favorably in the news media. Company Overall Sentiment UNITY Biotechnology Neutral IM Cannabis Very Positive Do analysts prefer UBX or IMCC? UNITY Biotechnology currently has a consensus target price of $3.75, indicating a potential upside of 1,994.97%. Given UNITY Biotechnology's stronger consensus rating and higher probable upside, equities research analysts clearly believe UNITY Biotechnology is more favorable than IM Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score UNITY Biotechnology 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50IM Cannabis 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryIM Cannabis beats UNITY Biotechnology on 9 of the 15 factors compared between the two stocks. Get UNITY Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for UBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UBX vs. The Competition Export to ExcelMetricUNITY BiotechnologyMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.08M$3.07B$5.70B$9.51BDividend YieldN/A2.36%4.69%4.01%P/E Ratio-0.1121.0428.0720.05Price / SalesN/A284.46448.5799.42Price / CashN/A42.7636.2258.56Price / Book0.468.378.665.87Net Income-$25.99M-$55.19M$3.25B$258.55M7 Day PerformanceN/A5.89%4.20%2.23%1 Month Performance-77.30%17.63%10.82%12.76%1 Year Performance-87.57%5.09%34.70%19.36% UNITY Biotechnology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UBXUNITY Biotechnology4.1328 of 5 stars$0.18-40.4%$3.75+1,995.0%-87.7%$3.08MN/A-0.1160Gap DownHigh Trading VolumeIMCCIM Cannabis0.2356 of 5 stars$3.04-11.1%N/A+29.3%$12.28M$39.44M-4.75340Positive NewsGap DownALVRAlloVirN/A$2.39-1.2%N/A-83.9%$12.05MN/A-0.12110High Trading VolumeIBIOiBio1.2553 of 5 stars$0.73-0.6%$4.30+491.7%-65.8%$12.00M$375K0.00100PHIOPhio Pharmaceuticals2.8961 of 5 stars$2.39-2.4%$14.00+485.8%-30.3%$11.47MN/A-0.3710News CoveragePositive NewsGap UpBTAIBioXcel Therapeutics3.964 of 5 stars$1.89-1.0%$42.60+2,154.0%-90.8%$11.45M$2.27M-0.1490Gap UpAIMDAinos1.5558 of 5 stars$2.64-4.7%N/A-24.0%$11.06M$20K-0.4140High Trading VolumeCYCNCyclerion Therapeutics2.5328 of 5 stars$3.37-4.8%N/A-8.5%$10.82M$2M-2.9130Positive NewsNKGNNKGen Biotech0.5901 of 5 stars$0.24flatN/A-83.8%$10.79MN/A-0.05N/AGap DownPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58MN/A0.0049LIXTLixte BiotechnologyN/A$3.92-3.4%N/A+79.7%$10.51MN/A-2.704Gap Down Related Companies and Tools Related Companies IM Cannabis Competitors AlloVir Competitors iBio Competitors Phio Pharmaceuticals Competitors BioXcel Therapeutics Competitors Ainos Competitors Cyclerion Therapeutics Competitors NKGen Biotech Competitors PHAXIAM Therapeutics Competitors Lixte Biotechnology Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UBX) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UNITY Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UNITY Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free UBX Stock Alerts